# A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema

> **NCT00676884** · PHASE2 · COMPLETED · sponsor: **Aerovance, Inc.** · enrollment: 25 (actual)

## Conditions studied

- Atopic Eczema

## Interventions

- **DRUG:** Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00676884
- **Lead sponsor:** Aerovance, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-07
- **Final completion:** 2006-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2008-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676884, "A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00676884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*